Marcinkowska, M.; Sobierajska, E.; Stanczyk, M.; Janaszewska, A.; Chworos, A.; Klajnert-Maculewicz, B.
Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy. Polymers 2018, 10, 187.
https://doi.org/10.3390/polym10020187
AMA Style
Marcinkowska M, Sobierajska E, Stanczyk M, Janaszewska A, Chworos A, Klajnert-Maculewicz B.
Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy. Polymers. 2018; 10(2):187.
https://doi.org/10.3390/polym10020187
Chicago/Turabian Style
Marcinkowska, Monika, Ewelina Sobierajska, Maciej Stanczyk, Anna Janaszewska, Arkadiusz Chworos, and Barbara Klajnert-Maculewicz.
2018. "Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy" Polymers 10, no. 2: 187.
https://doi.org/10.3390/polym10020187
APA Style
Marcinkowska, M., Sobierajska, E., Stanczyk, M., Janaszewska, A., Chworos, A., & Klajnert-Maculewicz, B.
(2018). Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy. Polymers, 10(2), 187.
https://doi.org/10.3390/polym10020187